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cases, and there is an urgent need to identify an effective
secondary preventive intervention to reduce the
recurrence of abuse, and to limit the impact that such
abuse has on children’s health. The secondary
prevention of abuse might require that the balance of
investment is now in favour of establishing from
existing evidence the core components of potentially
successful interventions.
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In this issue of The Lancet, David van Heel and co-workers
analyse the innate immunity driven by the mononuclear
cells of patients with Crohn’s disease. Using nanomolar
concentrations of muramyldipeptide in an ex-vivo
system, they report that pathways act synergistically for
the nucleotide oligomerisation domain 2 (Nod2, also
known as caspase-recruitment domain 15 or Card15)
and toll-like receptor (TLR). Co-activation of these two
pathways dramatically increased the production of
proinﬂammatory chemokines. This observation argues
for an integrated response of innate immunity.
Innate immunity is driven by a few pathogen-
associated molecular patterns that are present in most
of the non-eucaryote cells. The host molecules involved
in recognition of pathogen-associated molecular
patterns are known as pattern-recognition receptors.
Two main families of pattern-recognition receptors
have been discovered in human beings. TLRs are trans-
membranous molecules able to recognise lipopeptides
(TLR1 and 6), lipoteichoic acid (TLR2 and 6), DNA
from viruses (TLR3, 7, and 8), lipopolysaccharide
(TLR4), ﬂagellin (TLR5), bacterial DNA (TLR9), and still
unknown other molecules.1 Nods are seen as the
intracellular counterpart of the TLRs. Nod1 (also
known as Card4) and Nod2 are activated by some
fractions of peptidoglycan, a major component of the
bacterial wall.
The poorly puriﬁed pathogen-associated molecular
patterns used in initial experiments might have led to
erroneous conclusions. For example, Nod2 was
initially considered as a lipopolysaccharide receptor,
but it is now known that it recognises muramyl-
dipeptide, a peptidoglycan fraction. More recently,
Travassos et al showed that TLR2 is a receptor for
lipoteichoic acid but not for peptidoglycan.2 As a
result, Nod1 and Nod2 now appear with the
peptidoglycan-recognition proteins as the only known
proteins involved in the host response induced by
peptidoglycan. Peptidoglycan-recognition proteins are
considered as lytic enzymes (secreted or stored in
vesicles) while the Nods are seen as intracellular sensors
of peptidoglycan even if we do not yet know whether
peptidoglycan products interact physically with the
Nods.
The observation that pattern-recognition receptors
act in synergy is not a surprise: living systems are highly
integrated. Also, previous studies converged toward this
conclusion. The serine/threonine kinase Rip2 (receptor-
interacting protein 2, also known as RICK and CARDIAK)
is activated by Nod1 and Nod2. However, in Rip2
knock-out mice, the response to lipopolysaccharide,
peptidoglycan, and double-stranded RNA is impaired.3,4
These observations might be partly related to
contaminated preparations of pathogen-associated
molecular patterns as discussed above. However, the
demonstration that Rip2 can be recruited to TLR2-
signalling complexes after peptidoglycan stimulation
and that the effect of the reduced cytokine production
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in Rip2/ macrophages was due to defective
signalling from cell-surface receptors argue for a role of
Rip2 in the TLR pathway.4
More recently, NOD2 knock-out mice were shown
to be resistant to endotoxin challenge, suggesting
here too a connection between TLR4 and Nod2
pathways.5 Watanabe et al studied splenocytes from
these Nod2/ mice and found excess production
of interleukin 12 and interferon  in the deﬁcient
cells when stimulated with commercial non-puriﬁed
peptidoglycan.6 Uehara et al7 recently observed a
synergistic effect in terms of production of inter-
leukin 8, in the monocyte leukaemia cell-line THP1
co-stimulated with speciﬁc peptidoglycan fragments
and speciﬁc TLR2, TLR4, and TLR9 ligands.
van Heel and co-workers’ report conﬁrms the
connection between the TLR and Nod pathways. Nod
and TLR appear to act in synergy, in agreement with the
experiments performed in Rip2/ mice and THP1 cell
line but not in agreement with Watanabe et al’s results
on Nod2/ splenocytes.6 Discrepencies also appear
between studies for the types of TLRs involved in the
cooperation with Nod2 and for the chemokines
regulated by the interaction.
The mechanism of the cross-talk between the
pathways for pattern-recognition receptors is not
known, but we can speculate that Rip2 has a crucial role
(ﬁgure). There are physical and functional links between
Rip2 and both TLR and Nod pathways.3,4 Interestingly,
Rip2 seems to be also involved in adaptive immunity,
suggesting a much more developed network of
molecular interactions and the integration of both innate
and adaptive immune responses.3,4 The recent reports
that Nod2 interacts with other proteins containing
neuronal apoptosis-inhibitory-protein domains8 and
that Nod1 is negatively regulated by Card6 also argue for
a complex nexus involving the Nods and Rip2.9
In Crohn’s disease, at least 30 non-conservative
variations spread along the protein have been
reported,10 including three common mutations (R702W,
G908R, and 1007fs). However, the role of these
mutations is unknown. For most of them, inactivation
of nuclear-factor B after stimulation with muramyldi-
peptide is defective. In such cases, most data suggest
a change of sensitivity rather than an all-or-none
effect, as shown by van Heel and co-workers.
Unfortunately, a clear relation between response to
muramyldipeptide and lesions in Crohn’s disease is still
lacking, limiting the impact of any functional
characterisation of NOD2 mutations.
We cannot yet fully explain the disease mechanisms
in cases with NOD2 mutations. Consistent with van
Heel’s data, defective production of proinﬂammatory
chemokines is usually found for mutated Nod2.
However, since the ﬁrst studies, this observation was
difﬁcult to conciliate with the inﬂammation in Crohn’s
disease. As a consequence, alternative functions of
Nod2 have been looked for. Watanabe et al6 showed
that NOD2 limits the proinﬂammatory effects driven by
TLR2 stimulation. Chen et al11 also considered Nod2 as
an anti-inﬂammatory molecule under certain circum-
stances. Finally, Netea et al12 recently suggested that
Crohn’s disease results from defective production
of anti-inﬂammatory cytokines (interleukin 10 and
tumour growth factor ).
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Figure: Putative interaction between TLR and Nod pathways
TLR and Nod pathways are both involved in IKK activation through complex
signalling systems which ﬁnally induce translocation of nuclear-factor B in
nucleus and proinﬂammatory gene transcription. TRAF6/TAK1 complex seems
to interact with Nod1/Rip2 and Nod2/Rip2 complexes (red arrows), resulting in
integrated innate immune response in the cell. PAMPs=pathogen-associated
molecular patterns, MyD88=myeloid-differentiation primary-response protein 88,
IRAK=IL-1R-associated kinase, IL-1R=interleukin-1-receptor, TRAF=
tumour-necrosis-factor receptor-associated factor, MDP=muramyldipeptide,
Meso-DAP=meso-diaminopimelic acid, TAB=TAK1-binding protein,
NFB=nuclear-factor B, I=inhibitor of nuclear factor-B, IKK=IB-kinase.
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The walk from the disease to the gene is known to be
long and difﬁcult for complex genetic disorders. Crohn’s
disease illustrates the fact that the return walk from the
gene to the disease might also be hard.
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An ambitious project of collection of DNA samples from
indigenous peoples all over the world will undoubtedly
provide valuable insights into humanity’s migratory
past.1 However, such an exercise generates many and
complex questions about ﬁrst, technical standards
relating to taking, transporting, and storing samples for
DNA analysis, and second, the protection of genetic data
of people and populations.
Many of the samples taken for this project will,
inevitably, come from developing countries, or countries
involved in or recovering from some form of armed
conﬂict, whether war or widespread political violence. In
such countries, the International Committee of the Red
Cross (ICRC) is attempting to promote technical
standards and protection of genetic data mainly in
relation to verifying or refuting kinship relationships,
criminal investigation, and the identiﬁcation of human
remains.
Beyond the need for minimising both technical and
human errors by adherence to certain standards,2 there
is the question of what other objectives the analysis of a
persons’s DNA that serve. In most countries, the
national laws that protect personal data have been
extended to the protection of genetic data, because
people’s genetic data represents powerful information
and so could be misused or abused. Governments
recognise this. The 2003 UNESCO International
Declaration on Human Genetic Data3 recognises the
special status of human genetic data because they may:
“be predictive of genetic predispositions concerning
individuals and the power of predictability can be
stronger than assessed at the time of deriving the data 
. . . have a signiﬁcant impact on the family, including
offspring, extending over generations, and in some
instances on the [person’s] whole group [and] contain
information the signiﬁcance of which is not necessarily
known at the time of the collection of the biological
samples”. The Declaration stipulates that “any
collection, processing, use and storage of human
genetic data, human proteomic data and biological
samples shall be consistent with international law of
human rights” and that “clear, balanced, adequate and
appropriate information shall be provided to the person
whose prior, free, informed and express consent is
sought”. In other international institutions, govern-
ments have recognised the need for strict technical
standards to protect genetic data.2,4 However, the
resulting documents are not binding in a legal sense.
Some countries have no national laws to minimise
errors in DNA tests or to protect people’s genetic data;
the countries that are of greatest concern tend to be
where the ICRC is working and from which the samples
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